A5354/EARLIER: Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection . . . Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses

Study Location:

Washington

Topic:

Clinicaltrials.gov Link:

https://clinicaltrials.gov/ct2/show/NCT02859558?term=ACTG+5354&rank=1

Coordinator:

Anna Wimpleberg

Enrollment:

Open

Trial Period:

Ongoing

This study will include people who have very recently been infected with HIV and will start anti-HIV (antiretroviral) drugs right away to see how this may change HIV’s impact on the body. 

This study is trying to find out if starting antiretroviral drugs very early in HIV infection will change the following:

  • Limit the virus from getting into hidden areas of the body (“reservoirs”).
  • Change how the immune system helps to control the virus.

Men and women who:

  • Are at least 18 years old
  • Have had certain lab tests done that confirm very early HIV infection
  • Are willing to take antiretroviral drugs right away to treat HIV.

Categories

Location
Topic

Clinical Trials

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

P1060:  Phase II, parallel, randomized, clinical trials...

A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...

Read More

A5253: Sensitivity and Specificity of Mycobacterium...

An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...

Read More

P1077BF: Breastfeeding Version of the PROMISE Study...

1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...

Read More

NWCS 408: Examining Longitudinal Cytokine Profiles in HIV-TB...

Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...

Read More